How have CMPX and RXST total returns compared?

Over the past 5 years, CMPX delivered -22.79% and RXST delivered -19.19% annualized total return. Past performance doesn't predict future results.

Compass Therapeutics, Inc. (CMPX) vs RxSight, Inc. (RXST)

A side-by-side comparison of Compass Therapeutics, Inc. and RxSight, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CMPX

Compass Therapeutics, Inc.

$180M

$1.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

RXST

RxSight, Inc.

$192M

$4.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CMPX vs RXST

growth of $100 · dividends reinvested · last 5y

CMPX -80.4% (-27.8%/yr)RXST -70.3% (-21.5%/yr)RXST compounded faster over this window

CMPX RXST

CMPX vs RXST: by the numbers

•RXST is the larger company ($192M vs $180M market cap).
•Both run net losses; CMPX's is the smaller (0.00% vs -36.80% net margin).

Metrics side by side

Valuation

Metric	CMPX	RXST
P/S ratio	N/A	1.51
P/B ratio	1.08	0.73

Profitability

Metric	CMPX	RXST
Gross margin	0.00%	77.50%
Operating margin	0.00%	-43.20%
Net margin	0.00%	-36.80%
ROE	-44.23%	-17.83%
ROIC	-46.59%	-20.24%

Growth (annualized)

Metric	CMPX	RXST
Revenue CAGR (5Y)	N/A	48.85%
Total return CAGR (5Y)	-22.79%	-19.19%

Frequently asked

How have CMPX and RXST total returns compared?: Over the past 5 years, CMPX delivered -22.79% and RXST delivered -19.19% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CMPX analysis Full RXST analysis Interactive comparison tool

Dig into the metrics

Compass Therapeutics ROE RxSight ROE Compass Therapeutics operating margin RxSight operating margin Compass Therapeutics revenue growth RxSight revenue growth Compass Therapeutics free cash flow RxSight free cash flow

Compass Therapeutics & RxSight appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.